Cancer immunotherapy and heat-shock proteins: promises and challenges

被引:18
作者
Manjili, MH
Wang, XY
MacDonald, IJ
Arnouk, F
Yang, GY
Pritchard, MT
Subjeck, JR
机构
[1] Roswell Pk Canc Inst, Dept Cellular Stress Biol, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Canc Pathol & Prevent, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Radiat Oncol, Buffalo, NY 14263 USA
[4] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
cancer vaccines; danger signal; heat-shock proteins; immunotherapy; major histocompatibility complex;
D O I
10.1517/14712598.4.3.363
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recent mechanistic studies on the role of heat-shock proteins (HSPs) to induce innate and adaptive immune responses have resulted in conflicting reports. Whereas some groups reported that HSPs have direct immunological function, others emphasised the endotoxin contamination of HSP preparations and questioned the antigen-specificity of HSP vaccines. The present review will discuss these issues and suggest that HSPs have diverse and distinct immunological functions that could be superimposed on effects resulting from endotoxin contamination or misunderstood by using experimental procedures with inadequate controls. To understand the actual function of HSPs in their interaction with the immune system, methods and procedures need to be optimised and appropriate controls need to be used. These points should also clarify the conflicting findings about HSPs and promote our knowledge about other immuologically important components that may be present in HSP preparations.
引用
收藏
页码:363 / 373
页数:11
相关论文
共 96 条
[1]   Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96 [J].
Arnold, D ;
Wahl, C ;
Faath, S ;
Rammensee, HG ;
Schild, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (03) :461-466
[2]  
Arnold-Schild D, 1999, J IMMUNOL, V162, P3757
[3]   Novel signal transduction pathway utilized by extracellular HSP70 -: Role of Toll-like receptor (TLR) 2 AND TLR4 [J].
Asea, A ;
Rehli, M ;
Kabingu, E ;
Boch, JA ;
Baré, O ;
Auron, PE ;
Stevenson, MA ;
Calderwood, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15028-15034
[4]   HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine [J].
Asea, A ;
Kraeft, SK ;
Kurt-Jones, EA ;
Stevenson, MA ;
Chen, LB ;
Finberg, RW ;
Koo, GC ;
Calderwood, SK .
NATURE MEDICINE, 2000, 6 (04) :435-442
[5]   GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression [J].
Baker-LePain, JC ;
Sarzotti, M ;
Fields, TA ;
Li, CY ;
Nicchitta, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11) :1447-1459
[6]   Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway [J].
Basu, S ;
Binder, RJ ;
Suto, R ;
Anderson, KM ;
Srivastava, PK .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (11) :1539-1546
[7]   CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].
Basu, S ;
Binder, RJ ;
Ramalingam, T ;
Srivastava, PK .
IMMUNITY, 2001, 14 (03) :303-313
[8]   Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity [J].
Basu, S ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :797-802
[9]  
Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO
[10]  
2-C